Haemonetics | HAE - Ebitda


Haemonetics reported $96.17M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
Fresenius EUR 988M 37M Jun/2026
Fresenius Medical Care EUR 843.66M 19.66M Jun/2026
Globus Medical USD 279.84M 48.01M Jun/2026
Haemonetics USD 96.17M 91.87M Jun/2026
ICU Medical USD 110.03M 11.35M Jun/2026
Intuitive Surgical USD 1.2B 147.7M Jun/2026
Medtronic USD 2.63B 174M Jun/2026
Merit Medical Systems USD 104.39M 10.97M Jun/2026
Neogen USD 41.6M 3.8M Jun/2026
OraSure Technologies USD -17.7M 4.06M Dec/2025
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Quidel USD 129.3M 20.6M Jun/2026
ResMed USD 559.78M 9.06M Jun/2026
STAAR Surgical USD 20M 387K Jun/2026
Steris USD 443M 48.3M Mar/2026
Stryker USD 1.93B 357M Jun/2026
Teleflex USD 122.91M 47.28M Jun/2026
Terumo JPY 116.67B 58.79B Jun/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
US Physical Therapy USD 26.95M 7.6M Jun/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026